Survey of medication adherence in patients with schizophrenia - Korean ADHES data

Human Psychopharmacology

Volumn 21, Issue 8, 2006, Pages 533-537

  Kim, Sung Wan ^a   Yoon, Jin Sang ^a   Choi, Sung Ku ^b  

^a Chonnam National University Medical School   (South Korea)

^b Janssen Korea   (South Korea)

Author keywords

Adherence; ADHES; Medication; Schizophrenia

Indexed keywords

LONG ACTING DRUG; NEUROLEPTIC AGENT;

ARTICLE; ASIA; AWARENESS; CAREGIVER; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; KOREA; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; QUESTIONNAIRE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CAREGIVERS; DATA COLLECTION; HUMANS; KOREA; PATIENT COMPLIANCE; PATIENTS; PHYSICIANS; QUESTIONNAIRES; SCHIZOPHRENIA;

EID: 33846058780     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.812     Document Type: Article

References (19)

1. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. 1993. Assessment of insight in psychosis. Am J Psychiatry 150: 873-879.
2. Byerly M, Fisher R, Whatley K, et al. 2005. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 28: 129-133.
3. Cho MJ, Hahm BJ, Kim JK, et al. 2004. Korean Epidemiologic Cathchment Area (KECA) study for psychiatric disorders: prevalence of specific psychiatric disorders. J Korean Neuropsychiatr Assoc 43: 470-480.
4. Docherty JP, Grogg AL, Kozma C, Lasser R. 2002. Antipsychotic maintenance in schizophrenia: partial compliance and clinical outcome. Presented at The American College of Neuropsychopharmacology 41st Annual Meeting, 8-12 December, San Juan, Puerto Rico.
5. Fleischhacker WW, Oehl MA, Hummer M. 2003. Factors influencing compliance in schizophrenia patients. J Clin Psychiatry 64(Suppl. 16): 10-13.
6. Gharabawi GM, Lasser RA, Bossie CA, Zhu Y, Amador X. 2006. Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. Int Clin Psychopharmacol 21: 233-240.
7. Herings RM, Erkens JA. 2003. Increased suicide attempt rate among patients interrupting use of atypical antipsychotics. Pharmacoepidemiol Drug Saf 12: 423-424.
8. Kampman O, Laippala P, Vaananen J, et al. 2002. Indicators of medication compliance in first-episode psychosis. Psychiatry Res 110: 39-48.
9. Kim CK, Kim JW, Seo JM, Lee GZ, Kim GJ, Byun WT. 2000. Family burden of schizophrenics in the primary caregivers and siblings. J Korean Neuropsychiatr Assoc 39: 113-127.
10. Kim SW, Shin IS, Kim JM, Yang SJ, Shin HY, Yoon JS. 2006. Association between attitude toward medication and neurocognitive function in schizophrenia. Clin Neuropharmacol 29: 197-205.
11. Koukia E, Madianos MG. 2005. Is psychosocial rehabilitation of schizophrenic patients preventing family burden? A comparative study. J Psychiatr Ment Health Nurs 12: 415-422.
12. Masand PS. 2004. New outcomes in the treatment of schizophrenia: towards long-term re-integration of patients? Presented at 17th Congress of the European College of Neuropsychopharmacology 10-13 October, Stockholm, Sweden.
13. McCombs JS, Nichol MB, Stimmel GL, Shi J, Smith RR. 1999. Use patterns for antipsychotic medications in medicaid patients with schizophrenia. J Clin Psychiatry 60(Suppl. 19): 5-11.
14. Moore A, Sellwood W, Stirling J. 2000. Compliance and psychological reactance in schizophrenia. Br Psychol Soc 39: 287-295.
15. Razali MS, Yahya H. 1995. Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatr Scand 91: 331-335.
16. Robinson D, Woerner MG, Alvir JM, et al. 1999. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 56: 241-247.
17. Valenstein M, Copeland LA, Blow FC, et al. 2002. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 40: 630-639.
18. Velligan DI, Lam F, Ereshefsky L, Miller AL. 2003. Psychopharmacology: perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv 54: 665-667.
19. Weiden PJ, Kozma C, Grogg A, Locklear J. 2004. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 55: 886-891.